 CAMBRIDGE, Mass., April 07, 2022 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ: SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the Needham Healthcare Conference. The presentation will take place on Thursday, April 14, 2022 at 8:45 a.m. EDT. 